XTalks

SEPTEMBER 10, 2024

Amneal Pharmaceuticals and Shilpa Medicare have announced US Food and Drug Administration (FDA) approval of Boruzu, a ready-to-use formulation of bortezomib for subcutaneous or intravenous (IV) administration.

FDA Approval 105

FDA Approval Branding Drugs Pharmacy 105

XTalks

JUNE 29, 2021

Prescription digital medicine company Akili Interactive is set to launch a digital campaign for its FDA-approved video game for the treatment of attention deficit hyperactivity disorder (ADHD). The video game is called EndeavorRx and is the first and only FDA-backed therapy delivered through a video game experience.

FDA Approval 81

FDA Approval Pharmacy Marketing Medicine 81

XTalks

JANUARY 20, 2025

From Bristol-Myers Squibbs monumental acquisition of Celgene to Pfizers recent purchase of Seagen, these deals illustrate the strategies and ambitions driving innovation in life sciences. Following the merger, Actavis rebranded itself as Allergan, leveraging the strong recognition of Allergans brand.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

XTalks

JUNE 17, 2024

“We are thrilled with the FDA’s approval of Letybo. This is a huge achievement for Hugel as we focus on becoming a top aesthetics brand in the US,” said James Hartman, president of Hugel America in the news release. “As 134 How Does Letybo Work?

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research.

FDA Approval 101

FDA Approval Drugs Sales Development 101

XTalks

AUGUST 2, 2022

The US Food and Drug Administration (FDA) has granted approval to Azurity Pharmaceuticals’ liquid version of its epilepsy drug zonisamide (100 mg/5 mL; brand name Zonisade) as an adjunct therapy for the treatment of partial seizures in adults and pediatric patients 16 years of age and older with epilepsy.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Drugs 52

XTalks

DECEMBER 19, 2022

Register for this free webinar to learn about the value of imaging data as a real-world data source, and the power of linking it with clinical data stored in electronic health records (EHRs) to inform research across the drug and device lifecycle for life sciences. The NDA FDA approval is a milestone for the Thea Group.

Clinical Trials 98

Clinical Trials Clinical Trials FDA Approval Life Science 98

Pharmaceutical Technology

NOVEMBER 29, 2022

In 1970, the FDA approved ketamine as an anesthetic. In March 2019, the American regulator approved esketamine , an enantiomer of ketamine, for use in treatment-resistant depression as a nasal spray. Fox Foundation gave Sanacora a $2 million grant to study the drug’s use for depression in patients with Parkinson’s disease.

Research 275

Research Trials Drugs Generic Drugs 275

XTalks

NOVEMBER 1, 2024

Why it sold so well: Botox is FDA-approved for the treatment of chronic migraines and that is currently the only chronic condition for which it has received approval. It is a biologic drug available exclusively as a brand-name medication, with no generic or biosimilar forms available. billion in the US and $4.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

JANUARY 25, 2021

Cabenuva was actually expected to win FDA approval towards the end of 2019; however, manufacturing issues garnered rejection from the FDA at the time. Since then, Cabenuva received its first global approval in Canada in March 2020, followed by authorization in the EU in December under two separate brand names.

FDA Approval 52

FDA Approval Trials Clinical Trials Clinical Trials 52

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

APRIL 11, 2024

After backing from the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) last month, Johnson and Johnson (J&J) and Bristol Myers Squibb (BMS) scored FDA approvals for the use of their B-cell maturation antigen (BCMA)-targeting CAR T-cell therapies as earlier line treatment options for multiple myeloma.

FDA Approval 52

FDA Approval Manufacturing Trials Clinical Trials 52

XTalks

MAY 22, 2023

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

XTalks

DECEMBER 19, 2022

On December 16, 2022, AbbVie announced in a press release that the US Food and Drug Administration (FDA) approved Vraylar as an adjunctive therapy to antidepressants for the treatment of MDD in adults. This approval positions Vraylar as the first and only dopamine and serotonin partial agonist for the most common forms of depression.

FDA Approval 98

FDA Approval Clinical Trials Clinical Trials Trials 98

XTalks

FEBRUARY 8, 2024

Related: Veozah (Fezolinetant) Is a New Type of Drug for Menopausal Hot Flashes Lead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah) – Xtalks Life Science Podcast Ep. Bayer is preparing to file for FDA approval based on strong Phase III data it shared last month.

Life Science 105

Life Science Marketing Branding Drugs 105

XTalks

MAY 22, 2024

is one of the largest global medtech companies with diverse segments ranging from life science solutions to specialty diagnostics, analytical instruments and laboratory products and services. Danaher (Overall Rank 435) Danaher operates in three key areas: Biotechnology, Life Sciences and Diagnostics.

Life Science 95

Life Science Production FDA Approval Development 95

XTalks

OCTOBER 1, 2024

The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s (BMS) Cobenfy (xanomeline and trospium chloride), formerly KarXT, for the treatment of schizophrenia, the first new class of drug for the disorder to hit the market in over four decades.

FDA Approval 97

FDA Approval Trials Medicine Sales 97

XTalks

FEBRUARY 16, 2023

However, the company last aired the ad on May 2, 2022, the same day they announced the US Food and Drug Administration (FDA) approval of Quviviq. Quviviq is an FDA-approved prescription medicine that helps treat insomnia in adults, with a low risk of dependence and side effects. billion during the same period.

FDA Approval 105

FDA Approval Sales Branding Drugs 105

XTalks

SEPTEMBER 28, 2023

In the first half of 2023, pharmaceutical drugs accounted for half of the most viewed new brands by TV ad impressions, according to an iSpot.tv The drug took off quickly after its approval given the growing popularity of GLP-1 agonists like rival Novo Nordisk’s Ozempic for the treatment of diabetes and off-label use for weight loss.

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

JANUARY 6, 2021

Some include Mind Medicine, Compass Pathways and Champignon Brands. Mind Medicine has multiple FDA-approved trials that are ongoing in multiple jurisdictions and geographies, along with drug developments efforts that include substances such as psilocybin, LSD, MDMA, DMT and their Ibogaine derivative, 18-MC. Champignon Brands.

Drugs 97

Drugs Clinical Trials Clinical Trials Medicine 97

XTalks

JULY 19, 2024

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. In May, Eli Lilly reached a settlement with one of the medical spas.

Pharmacy 104

Pharmacy Drugs Production Sales 104

XTalks

MARCH 27, 2023

The first line of treatment for invasive candidiasis is a subset of antifungal medications called echinocandins, which includes caspofungin (brand name Cancidas), the drug that rezafungin was compared with in clinical trials. For example, Scynexis Inc.

Clinical Trials 98

Clinical Trials Clinical Trials Branding Trials 98

XTalks

FEBRUARY 9, 2024

For healthcare professionals and stakeholders in the life sciences sector, understanding the top-performing cardiovascular drugs is not just about recognizing their financial success. Marketing in both cardiac and hematological indications has contributed to its success, which continues to grow in emerging markets globally.

Sales 59

Sales FDA Approval Drugs Marketing 59

XTalks

AUGUST 31, 2023

Related: Non-Stimulant ADHD Drugs: Qelbree Versus Strattera According to the FDA, generics “work in the same way and provide the same clinical benefit and risks as their brand-name counterparts.” The entry of Vyvanse generics into the market will certainly be welcomed by patients as generics are cheaper than the branded version.

Marketing 98

Marketing Branding Drugs Sales 98

XTalks

SEPTEMBER 6, 2024

Novartis is investing $200 million into expanding its Indianapolis, Indiana, site for in-house production of radioisotopes and constructing a brand new one in Carlsbad, California. The facilities are part of the company’s plans to expand its manufacturing and supply chain capabilities.

Development 105

Development Manufacturing Marketing Hormones 105

XTalks

MAY 17, 2024

The settlement requires Totality to take several specific corrective actions, which include refraining from making any statements that suggest the spa’s products are genuine, FDA-approved Lilly products, and stopping the use of Eli Lilly branding in promoting any of the products.

Sales 52

Sales FDA Approval Pharmacy Production 52

XTalks

JUNE 14, 2023

The exact cost of Vevye has not been publicly disclosed; however, it is estimated that the price of Vevye may be in the range of similar cyclosporine ophthalmic emulsions, such as brand-name Restasis that carries a list price of $645.63 One such approved medication is Miebo , an ophthalmic solution developed by Bausch + Lomb and Novaliq.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research.

FDA Approval 52

FDA Approval Drugs Sales Development 52

XTalks

SEPTEMBER 21, 2023

The company said it cannot “validate the safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product.” Since the compounded versions of Mounjaro are not FDA approved, Lilly said they may expose patients to potentially serious health risks.

Pharmacy 59

Pharmacy FDA Approval Drugs Containment 59

pharmaphorum

SEPTEMBER 21, 2021

AstraZeneca has unveiled plans to build a brand new manufacturing facility at a site in Ireland operated by its recent acquisition Alexion, providing employment for around 100 workers including scientists and engineers. “This significant investment will ensure the AstraZeneca supply network is fit for the future.”

Manufacturing 59

Manufacturing Life Science Medicine FDA Approval 59

pharmaphorum

NOVEMBER 22, 2021

Skip created a virtual classroom to test children with ADHD and is now working with a company that collects data with this application to support the path to FDA approval. Pharma can also utilise VR technology to aid in their research, such as testing new medications for children with ADHD. About the author .

Clinical Trials 116

Clinical Trials Clinical Trials Gerontology Trials 116

XTalks

JUNE 8, 2022

Related: Cyltezo Becomes First FDA-Approved Interchangeable Humira Biosimilar. Biosimilars are less expensive than their reference products because of lower R&D costs and a shorter and cheaper path to approval due to reduced clinical trial requirements.

Generic Pharmaceutical 69

Generic Pharmaceutical Production Medicine Branding 69

XTalks

MARCH 16, 2022

Exact Sciences and long-time colon cancer screening advocate and award-winning journalist Katie Couric have teamed up for Colon Cancer Awareness Month this March in a TV ad for the company’s at-home screening test Cologuard. The ad is part of Exact Sciences’ “Mission to Screen” campaign that was launched this week.

DNA 98

DNA FDA Approval Doctor Doctors 98

XTalks

OCTOBER 21, 2024

Novartis’s latest attempt to block the US Food and Drug Administration’s (FDA) approval of a generic version of its blockbuster heart failure drug, Entresto (sacubitril/valsartan), has been shot down by a federal court. Novartis plans to continue its legal battle.

FDA Approval 52

FDA Approval Drugs Pharma Companies Production 52

XTalks

FEBRUARY 21, 2025

BioRad Laboratories Life science research and diagnostics giant BioRad announced a 5% workforce reduction over 350 employees with the most significant cuts at its Hercules headquarters, along with additional layoffs at its Pleasanton and Richmond locations.

Life Science 66

Life Science Marketing Gene Therapy Research 66

XTalks

APRIL 5, 2024

The life expectancy after symptoms develop is around two to five years. Relyvrio’s FDA approval was seen as controversial from the get-go as it was based on data from a small Phase II trial that showed a modest slowing of disease progression in patients who received the drug.

Trials 98

Trials Drugs Marketing FDA Approval 98

XTalks

DECEMBER 14, 2023

The US Food and Drug Administration (FDA) has approved Iwilfin (eflornithine) to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have had at least a partial response to previous multiagent, multimodality therapy including anti-GD2 immunotherapy.

FDA Approval 52

FDA Approval Dermatology Drugs DNA 52